LATEST NEWS
Prof Richard Scolyer gains strength from widespread support
Family, friends, colleagues and MIA provide support and strength to Prof Richard Scolyer as he undergoes treatment for a glioblastoma (brain cancer).
Melanoma Science Race Against Brain Cancer – National Press Club
National Press Club Address - “Melanoma science in the race against brain cancer. Using a terminal diagnosis as a path for good.”
A life-saving partnership with Toyota Material Handling
Read more about the partnership, which includes vital financial support for MIA research, and also awareness initiatives for the logistics sector.
A life-changing Flinders Ranges Adventure!
Our 11 Flinders Ranges trekkers have returned safely with new friends, a wonderful sense of achievement and many great memories to treasure. See all the pics and support their efforts!
Cutaneous melanoma: a contemporary overview published in The Lancet
A contemporary overview of Cutaneous melanoma, co-authored by MIA, has been published in The Lancet, one of the world's leading medical journals.
Prof Richard Scolyer receives SMR Lifetime Achievement Award
This prestigious award from the 'Society for Melanoma Research' recognises the contribution Richard has made to global melanoma research over the course of his career.
MIA’s MISSION
ZERO DEATHS FROM MELANOMA
MIA will achieve its mission through 3 pillars of action: Research, Clinical Care & Education.
MIA conducts its research under 4 themes: Prevention, Risk & Clinical Detection – Early Melanoma – Advanced Melanoma – Supportive Care & Survivorship.
1300
It is estimated 1300
Australians will die from
melanoma this year
30 mins
1 Australian is diagnosed
with melanoma every 30
minutes
90%
If caught early 90% of
melanomas can be cured
by surgery
Age 20-39
Melanoma is the most
common cancer affecting
Australians aged 20 to 39
